Keya Medical, a leading developer of medical AI technology, has received the Most Growth Enterprise Award granted by iiMedia Research, a third-party data mining and analysis company headquartered in China.

Keya Medical’s recognition was announced at the Annual Peak List of 2020 New Economy Industry Online Ceremony hosted by iiMedia Research. The list recognizes leading companies that are playing a pivotal role in new economy industries. According to iiMedia Research, the companies recognized on the list demonstrate significant investment value, development potential, and innovation capability.

Since the company was founded in 2016, Keya Medical has committed to developing solutions using AI that deliver clinical value throughout the patient care process. Keya Medical’s flagship product, DeepVessel FFR, uses deep learning technology to non-invasively perform a physiological functional assessment of the coronary arteries from coronary computed tomography angiography (CTA) scans. In 2020, DeepVessel FFR became the first AI software medical device to receive regulatory clearance from the Chinese National Medical Products Administration. Keya Medical is continuing to develop a comprehensive R&D product pipeline that includes diagnosis and treatment solutions that leverage AI to improve patient care, physician satisfaction, and clinical efficiency.

As an international leader in the medical AI industry, Keya Medical adheres to the corporate philosophy of developing solutions that solve real clinical challenges. Keya Medical will continue collaborating with healthcare organizations to develop deep learning-based diagnosis and treatment solutions that will deliver clinical value throughout the patient care process.

About Keya Medical
Keya Medical Technology Co. Ltd. is a medical technology company that is dedicated to the development and commercialization of deep learning-based medical devices for disease diagnosis and treatment to revolutionize the medical device industry. Since 2016, the company has developed solutions for specialities, including cardiology, radiology, neurology, pathology, and surgery. Today, Keya Medical collaborates with 728 hospitals to improve care delivery on a global scale. To learn more about Keya Medical, follow us on LinkedIn and Twitter.